Sight Sciences Reports First Quarter 2024 Financial Results

Azenta Reports First Quarter Results for Fiscal 2024, Ended ...

Revenue was $154 million, down 13% year over year. Organic revenue declined 15% year over year, which excludes the impacts of foreign exchange ...

Boston Scientific Announces Results for First Quarter 2024

MARLBOROUGH, Mass., April 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter ...

Scientific Industries Reports Third Quarter 2024 Financial Results

Bioprocessing Systems Operations revenues increased 6.6% to $452,500 for the three months ended September 30, 2024 compared to $424,200 in the ...

Kodiak Sciences Announces Recent Business Highlights and First ...

The net loss for the first quarter of 2024 was $43.0 million , or $0.82 per share on both a basic and diluted basis, as compared to a net loss ...

Regeneron Reports First Quarter 2024 Financial and Operating ...

Regeneron Reports First Quarter 2024 Financial and Operating Results ; First quarter 2024 revenues decreased 1% to $3 .15 billion versus first ...

Ionis reports third quarter 2024 financial results

R&D revenue increased for the nine months ended September 30, 2024 compared to the same period last year primarily due to the amortization of ...

Valneva Reports Nine-Month 2024 Financial Results and Provides ...

This increase was primarily due to €57.5 million net proceeds from the recent private placement completed in the third quarter of 2024, while ...

Kenvue reports first quarter 2024 results - A new view of care

First quarter Adjusted operating income margin1 was 22.0% vs 21.3% in the prior year period as robust Adjusted gross profit margin expansion was ...

Semler Scientific® Reports First Quarter 2024 Financial Results

Semler Scientific® Reports First Quarter 2024 Financial Results · First quarter revenues were $15.9 million , a decrease of 13% · First quarter net income was ...

Thermo Fisher Scientific Reports First Quarter 2023 Results - Investors

First quarter revenue was $10.71 billion, 9% lower versus the same quarter last year. Core organic revenue growth was 6%. First quarter GAAP ...

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial ...

Research and development expenses for the third quarter 2024 were approximately $9.1 million, compared to $21.0 million for the same period in ...

Shattuck Labs Reports Third Quarter 2024 Financial Results and ...

Research and Development (R&D) Expenses: R&D expenses were $16.3 million for the quarter ended September 30, 2024, as compared to $24.2 million ...

Kezar Life Sciences Reports First Quarter 2024 Financial Results ...

Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update · $179.8 million as of March 31, 2024 , compared to ...

Sight Sciences, Inc. (SGHT) 10-Q Quarterly Report November 2024

Sight Sciences, Inc. · Generated total revenue of $21.4 million, an increase of 11% compared to the prior quarter and a decrease of 9% compared to the same ...

Air Products Reports Fiscal 2024 Fourth Quarter GAAP EPS of $8.81 ...

Investor Contacts: · GAAP EPS# of $8.81, up 186 percent; GAAP net income of $2.0 billion, up 181 percent; and GAAP net income margin of 61.2 ...

SGHT - Sight Sciences Inc Stock Price and Quote - FINVIZ.com

Apr-18-24 04:05PM · Sight Sciences to Report First Quarter Financial Results on May 2, 2024. (GlobeNewswire) ; 04:05PM, Upgrade to FINVIZ*Elite to get real-time ...

Kamada Reports Continued Profitable Growth with Strong Third ...

Total revenues for the first nine months of 2024 were $121.9 million, which represents year-over-year growth of 15%, and adjusted EBITDA was ...

Innate Pharma Reports Third Quarter 2024 Business Update and ...

Innate” or the “Company”) today announced its business update and financial results for the first nine months of 2024. "I'm honored to join ...

Financials - Quarterly Results - Rocket Lab - Investor Relations

Business Highlights for the Second Quarter 2024, plus updates since June 30, 2024: Achieved our highest revenue quarter in Company history at $106 million.

Investor relations - Bristol Myers Squibb

... Scientific Sessions 2024. 11/05/2024. Bristol Myers Squibb to ... 10/31/2024. Bristol Myers Squibb Reports Third Quarter Financial Results for 2024.